SPRYCEL Receives CHMP Positive Opinion For The Treatment Of Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive CML In Chronic Phase

Posted by rob on October 25, 2010 under Uncategorized | Comments are off for this article

Bristol-Myers Squibb today announced that SPRYCEL (dasatinib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive Chronic Myelogenous Leukaemia in Chronic Phase (CML-CP)… (Source: Health News from Medical News Today)

DNA detection of chronic myelogenous leukemia by magnetic nanoparticles

Posted by rob on under Uncategorized | Comments are off for this article

Kulachart Jangpatarapongsa, Duangporn Polpanich, Vichanan Yamkamon, Yuranun Dittharot, Jutharat Peng-On, Raweewan Thiramanas, Suradej Hongeng, Saengsuree Jootar, Lalida Charoenmak, Pramuan Tangboriboonrat
(Paper from Analyst)
Kulachart Jangpatarapongsa, Analyst, 2011, DOI: 10.1039/c0an00374c
To cite this article before page numbers are assigned, use the DOI form of citation above.

The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC – Analyst latest articles)